Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.